Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
27
28
29
30
31
1
2
12:00 AM - NextGen UGM 2025
3
4
6
7
8
9
10
11
12
13
14
15
16
17
10:00 AM - MEDICA 2025
18
19
20
21
22
23
24
25
26
27
28
29
30
NextGen UGM 2025
2025-11-02 - 2025-11-05    
12:00 am
NextGen UGM 2025 is set to take place in Nashville, TN, from November 2 to 5 at the Gaylord Opryland Resort & Convention Center. This [...]
Preparing Healthcare Systems for Cyber Threats
2025-11-05    
2:00 pm
Healthcare is facing an unprecedented level of cyber risk. With cyberattacks on the rise, health systems must prepare for the reality of potential breaches. In [...]
MEDICA 2025
2025-11-17 - 2025-11-20    
10:00 am - 5:00 pm
Expert Exchange in Medicine at MEDICA – Shaping the Future of Healthcare MEDICA unites the key players driving innovation in medicine. Whether you're involved in [...]
Events on 2025-11-02
NextGen UGM 2025
2 Nov 25
TN
Events on 2025-11-05
Events on 2025-11-17
MEDICA 2025
17 Nov 25
40474 Düsseldorf

Events

Press Releases

Avanos Medical Acquires Nexus Medical to Enhance Critical Care Nutrition and Medication Delivery

avanos-EMR industry

ALPHARETTA, Ga., Sept. 15, 2025 /PRNewswire/ — Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, announced the acquisition of Nexus Medical, LLC, a privately held medical device firm based in Lenexa, Kansas.

Nexus manufactures the proprietary TKO® anti-reflux needleless connector, designed to ensure safer and more reliable nutrition and medication delivery in critical care settings such as Neonatal and Pediatric Intensive Care Units (NICUs and PICUs).

This acquisition complements Avanos’ Specialty Nutrition Systems business and strengthens its commitment to providing safe, effective therapy solutions for neonatal patients.

“This deal aligns with our strategy to deliver smarter, safer critical care solutions,” said Dave Pacitti, Avanos CEO. “We’re excited to integrate Nexus TKO® technology and expand our portfolio, investing in innovations that support clinicians in delivering consistent care and improving patient outcomes.”

The TKO® connector features a patented, pressure-activated tri-seal silicone valve that reduces blood reflux—a key factor in catheter blockages, therapy delays, and infection risks during IV nutrition and medication delivery.\*

“Kerr Holbrook, Avanos’ chief commercial officer, added, “Nexus TKO® is a natural fit for our Specialty Nutrition Systems and will bring immediate value to NICU and PICU care. It’s a trusted, practical solution that helps clinicians minimize interruptions and provide therapy more consistently and easily.”

Avanos funded the acquisition using available cash and anticipates it will immediately boost both revenue growth and earnings per share.

About Avanos Medical
Avanos Medical (NYSE: AVNS) is a medical technology company dedicated to delivering clinically advanced medical device solutions that help patients return to what matters most. Based in Alpharetta, Georgia, Avanos focuses on addressing critical healthcare needs such as providing essential nutrition support from hospital to home and reducing opioid use to aid patient recovery after surgery. The company designs, manufactures, and markets globally recognized brands and holds leading positions in several product categories. For more information, visit www.avanos.com and follow Avanos Medical on X (@AvanosMedical), LinkedIn, and Facebook.

About Nexus Medical
Founded in 2001, Nexus Medical pioneered the anti-reflux category in needleless connectors to address the issues caused by blood reflux in IV catheters, such as thrombotic occlusions, catheter failure, and infections. As the most extensively studied needleless connector on the market, Nexus TKO® anti-reflux technology offers an evidence-based solution that simplifies IV therapy and enhances patient safety. For more information, call (913) 451-2234 or visit www.nexusmedical.com